For those of you who can speak German, here is a short clip from a film about Psilocybin as medicine featuring Heffter Board Member Dr. Franz Vollenweider.Sie wirken ähnlich wie die Droge LSD auf das Gehirn: Magic mushrooms verändern die Wahrnehmung, machen euphorisch und können...
A CBS News program on addiction features Heffter researcher Stephen Ross and his upcoming study on the use of psilocybin to treat alcoholism. The interview, which is part of the #14Days on the Wagon series on CBS, focuses on the spiritual dimension of addiction.“Ross believes...
An article in Newsweek magazine reports on speakers and topics from the recent Horizons conference in New York City. In “Ecstasy and Acid in Your Medicine Cabinet? Doctors Explore Psychedelics,” published on October 14th, 2014, writer Douglas Main provides an overview of past and current...
An article in The Psychologist, the official publication of the British Psychological Society, covers recent work on the use of psilocybin to treat emotional distress in cancer patients. “Experiences of hallucinogen treatment”–published in the magazine’s September, 2014 issue–focuses on studies by Heffter researchers Charles Grob...
In this TEDx talk, Heffter board member Roland Griffiths speaks about his research on psilocybin and the mystical experience. Griffiths and his team at Johns Hopkins recruited 36 individuals with experience in spiritual or religious activities but no prior use of psychedelics. Although the primary...
Heffter researcher Matt Johnson and his colleagues at Johns Hopkins University have completed a study showing that psilocybin (aka “magic mushrooms”) is a useful treatment for heavy smokers who want to quit. According to Bloomberg.com writer Michelle Fay Cortez:Just two or three experiences with the hallucinogenic...
A recent article in Scientific American highlights the need to reform federal drug policy. In “Turn On, Tune In, Get Better: Psychedelic Drugs Hold Medical Promise,” writer Roni Jacobson describes how the FDA and DEA created a Catch-22 situation for scientists who study psychedelics. The...
An article in the UK newspaper The Independent profiles Dr. Robin Carhart-Harris, a researcher at the Centre for Neuropsychopharmacology at Imperial College. Writer Laurence Phelan interviews Carhart-Harris about the history and current status of psychedelic research as well as his work using fMRI scanning technology to...
Two upcoming conferences may be of interest to readers of this website. The World Ayahuasca Conference will be held from September 25th to the 27th in Ibiza, Spain. “The World Ayahuasca Conference 2014, organized by the ICEERS Foundation, aims to be a multidisciplinary event that brings together...
An article on the news site Vox features an in-depth interview with Heffter board member Dr. Charles Grob. “The Case for Medical LSD, Mushrooms, and Ecstasy,” by German Lopez, surveys the history and current status of psychedelic research. Dr. Grob discusses the potential of psychedelic...
